CVM
IONS icon

Cheviot Value Management’s Ionis Pharmaceuticals IONS Stock Holding History

Cheviot Value Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22K Hold
28
– – ﹤0.01% 367
2026
Q1 		$2.1K Hold
28
– – ﹤0.01% 350
2025
Q4 		$2.29K Hold
28
– – ﹤0.01% 342
2025
Q3 		$2.06K Hold
28
– – ﹤0.01% 371
2025
Q2 		$1.17K Hold
28
– – ﹤0.01% 370
2025
Q1 		$942 Buy
+28
New +$917 ﹤0.01% 396

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cheviot Value Management's IONS Position: Q2 2026 in Review

Cheviot Value Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 28 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #367.

Cheviot Value Management first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.29K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Cheviot Value Management held 28 shares of Ionis Pharmaceuticals worth $2.22K as of Q2 2026.
  • Cheviot Value Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Cheviot Value Management's portfolio in Q2 2026, its #367 holding.
  • Cheviot Value Management first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Cheviot Value Management's Ionis Pharmaceuticals position peaked at $2.29K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.